跳轉至內容
Merck
全部照片(1)

Key Documents

Y0001104

Picosulfate for system suitability

European Pharmacopoeia (EP) Reference Standard

同義詞:

Sodium picosulfate

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C18H13NNa2O8S2
CAS號碼:
分子量::
481.41
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

sodium picosulfate

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

InChI

1S/C18H15NO8S2.2Na/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25;;/h1-12,18H,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2

InChI 密鑰

GOZDTZWAMGHLDY-UHFFFAOYSA-L

尋找類似的產品? 前往 產品比較指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Picosulfate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Drug eruption due to sodium picosulfate.
Asuka Ishikawa et al.
European journal of dermatology : EJD, 22(3), 410-411 (2012-03-13)
Naoki Hosoe et al.
Journal of gastroenterology and hepatology, 27(10), 1617-1622 (2012-06-01)
In Japan, patient acceptance of bowel preparation methods before colonoscopy remains unknown. This study was conducted to evaluate the patient acceptance of sodium phosphate (NaP) tablets and polyethylene glycol solution (PEG) with sodium picosulfate. One hundred patients were randomized into
Annie O O Chan
Hong Kong medical journal = Xianggang yi xue za zhi, 18(5), 388-394 (2012-09-29)
OBJECTIVES. Although Picolax (sodium picosulphate and magnesium citrate) has been widely documented for use in bowel preparation, there is limited literature on its efficacy in the treatment of constipation. Refractory constipation is a more difficult situation with limited treatment options
Douglas K Rex et al.
Gastrointestinal endoscopy, 78(1), 132-141 (2013-04-10)
New bowel cleansers for colonoscopy that lead to improved efficacy, safety, and tolerability are needed. This study evaluated a nonphosphate, dual-action, low-volume, orange-flavored preparation containing sodium picosulfate and magnesium citrate (P/MC). Multicenter, assessor-blinded, randomized, noninferiority study. University hospitals, academic medical
G Manes et al.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 15(9), 1145-1153 (2013-04-16)
The study compared the efficacy, safety and tolerability of a low-volume picosulphate/magnesium citrate preparation with that of polyethylene glycol plus ascorbic acid (PEG + ASC) in a randomized clinical trial (RCT). A multicentre randomized, single-blinded study was designed. Adult outpatients

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務